ALYSSA ORTEGA: Open Payments
NPI 1841803244 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,990 in 89 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $762 · 2025 $2,990
Food & beverage: $2,842Education: $148
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 17 | $494 |
| UCB, Inc. | 12 | $420 |
| Novartis Pharmaceuticals Corporation | 6 | $385 |
| LEO Pharma Inc. | 5 | $286 |
| ABBVIE INC. | 8 | $263 |
| Organon LLC | 13 | $199 |
| GENZYME CORPORATION | 2 | $177 |
| E.R. Squibb & Sons, L.L.C. | 7 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $144 |
| Hill Dermaceuticals, Inc. | 1 | $98 |
Products named: NEMLUVIO, Bimzelx, ANZUPGO, DUPIXENT, RINVOQ, Sotyktu, Rhapsido, SPRAVATO.
Industry payments across CA — which companies pay providers there.
